Ventricular assist devices are implantable mechanical pumps used in controlling the blood flow from ventricles of heart to the rest of body. These devices replicate the functioning of ventricles and are implanted to the end of heart and to helps the flow of blood from ventricles to the body. These flow pumps could be either pulsatile or continuous, where the continuous flow pump circulates blood continuously, while the pulsatile pump mimics the natural heart pulse.
The major factors that drive the growth of the global ventricular assist devices market are growing patients' pool with heart failures and shortage of heart donors. Additionally, the technically advanced VAD (DuraHeart, HeartMate III) are devices that add to the market growth.
The global Ventricular Assist Devices(VAD) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ventricular Assist Devices(VAD) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ventricular Assist Devices(VAD) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ventricular Assist Devices(VAD) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ventricular Assist Devices(VAD) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
HeartWare International
Abiomed
Thoratec
Syncardia System
Sun Medical Technology Research
St. Jude Medical
Reliant Heart
Jarvik Heart
Cardiac Assist
Berlin Heart
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
LAVD
RVAD
BiVAD
Segment by Application
Hospital
ASCs
The major factors that drive the growth of the global ventricular assist devices market are growing patients' pool with heart failures and shortage of heart donors. Additionally, the technically advanced VAD (DuraHeart, HeartMate III) are devices that add to the market growth.
The global Ventricular Assist Devices(VAD) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ventricular Assist Devices(VAD) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ventricular Assist Devices(VAD) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ventricular Assist Devices(VAD) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ventricular Assist Devices(VAD) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
HeartWare International
Abiomed
Thoratec
Syncardia System
Sun Medical Technology Research
St. Jude Medical
Reliant Heart
Jarvik Heart
Cardiac Assist
Berlin Heart
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
LAVD
RVAD
BiVAD
Segment by Application
Hospital
ASCs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.